Cheng-Pin Chen to Treatment Outcome
This is a "connection" page, showing publications Cheng-Pin Chen has written about Treatment Outcome.
Connection Strength
0.033
-
A multicenter, randomized, open-label, controlled trial to evaluate the efficacy and tolerability of hydroxychloroquine and a retrospective study in adult patients with mild to moderate coronavirus disease 2019 (COVID-19). PLoS One. 2020; 15(12):e0242763.
Score: 0.033